Early postoperative cognitive recovery after remifentanil-propofol or sufentanil-propofol anaesthesia for supratentorial craniotomy: a randomized trial

Eur J Anaesthesiol. 2007 Feb;24(2):122-7. doi: 10.1017/S0265021506001244. Epub 2006 Aug 29.

Abstract

Background and objective: This study was designed to evaluate early postoperative cognitive recovery after total intravenous anaesthesia with remifentanil-propofol or sufentanil-propofol in patients undergoing craniotomy for supratentorial expanding lesions.

Methods: Sixty patients were consecutively enrolled, and randomly assigned to one of two study groups: remifentanil-propofol or sufentanil-propofol anaesthesia. To evaluate cognitive function the Short Orientation Memory Concentration Test (SOMCT) and Rancho Los Amigos Scale (RLAS) were administered to all patients in a double-blind procedure before surgery at 15, 45 min and 3 h after extubation.

Results: Mean extubation time was similar in the two groups (13 +/- 5 min vs. 19 +/- 6 min). A significantly larger number of patients in the remifentanil-propofol group than in the sufentanil-propofol group required antihypertensive medication postoperatively to maintain mean arterial pressure within 20% of baseline (18/30 vs. 4/29; P = 0.0004). Intergroup analysis showed no differences in baseline SOMCT scores (28 +/- 1 vs. 28 +/- 1) whereas mean SOMCT scores at 15, 45 min and 3 h after extubation were significantly higher in the remifentanil-propofol group (30 patients) than in the sufentanil-propofol group (29 patients) (22 +/- 3 vs. 16 +/- 3; P < 0.0001 and 27 +/- 1 vs. 22 +/- 3; P < 0.0001; 28 +/- 1 vs. 26 +/- 2; P = 0.0126).

Conclusions: In conclusion, propofol-remifentanil and propofol-sufentanil are both suitable for fast-track neuroanaesthesia and provide similar intraoperative haemodynamics, awakening and extubation times. Despite a higher risk of treatable postoperative hypertension propofol-remifentanil allows earlier cognitive recovery.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Anesthesia Recovery Period*
  • Anesthetics, Combined / adverse effects
  • Anesthetics, Combined / therapeutic use
  • Anesthetics, Intravenous / adverse effects
  • Anesthetics, Intravenous / therapeutic use
  • Blood Pressure / drug effects
  • Cognition / drug effects*
  • Craniotomy / methods*
  • Double-Blind Method
  • Female
  • Humans
  • Intubation, Intratracheal / methods
  • Male
  • Memory, Short-Term / drug effects
  • Middle Aged
  • Piperidines / adverse effects*
  • Piperidines / therapeutic use
  • Postoperative Period
  • Propofol / adverse effects*
  • Propofol / therapeutic use
  • Prospective Studies
  • Remifentanil
  • Sufentanil / adverse effects*
  • Sufentanil / therapeutic use
  • Supratentorial Neoplasms / surgery*
  • Time Factors

Substances

  • Anesthetics, Combined
  • Anesthetics, Intravenous
  • Piperidines
  • Sufentanil
  • Remifentanil
  • Propofol